Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1

Conditions

Head and Neck Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Radiation Injuries 2Xerostomia 1Uterine Cervical Neoplasms 1Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Salivary Gland Neoplasms 1Prostatic Neoplasms 1Multiple Myeloma 1Mucositis 1Deglutition Disorders 1Colorectal Neoplasms 1Brain Neoplasms 1

Interventions

dexamethasone acetate 1dexamethasone 21-phosphate 1auricularum 1Range of Motion, Articular 1Radiotherapy 1Parenteral Nutrition 1Paclitaxel 1Fibroblast Growth Factor 7 1Enteral Nutrition 1Endoscopy, Digestive System 1Dexamethasone 1Carboplatin 1Calcium Dobesilate 1Amifostine 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Deglutition Disorders × Amifostine × Clear all
NCT00503776 2017-06-20

Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia

Vanderbilt-Ingram Cancer Center

Phase 2 Terminated
41 enrolled 12 charts
Head & NeckOther

Squamous Cell Carcinoma of Head and Neck, Deglutition Disorders, Head and Neck Neoplasms, Radiation Injuries, Salivary Gland Neoplasms, Xerostomia, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡